Boost Your Viral Production Efficiency with MinneBio Ultra-Active Nuclease
Viruses have traditionally been used in the development of viral vaccines. In recent years, recombinant viral vectors have become widely adopted as gene delivery carriers in the development of chimeric antigen receptor (CAR) T cells, other genetically modified cell therapies, and gene therapy applications—owing to their ability to efficiently deliver genetic material into target cells. […]
